|

GD2-CAR-T cell Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • The General Hospital of Western Theater Command1

Indications

  • Neuroblastoma1
  • Cancer1

Other1 trial

A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.